Skip to main content
OpenTrials

Clinical trial condition

Thrombocytopenia

Explore clinical trials studying Thrombocytopenia. Study availability and eligibility vary by location and protocol.

403 public trials 115 recruiting studies
Refine in advanced search Browse all conditions

Thrombocytopenia trial results

Completed

A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

NCT04188379

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigator Site 0010038 Tucson, Arizona, United States
  • Investigator Site 0010045 Washington D.C., District of Columbia, United States
  • Investigator Site 0010034 Jacksonville, Florida, United States
  • Investigator site 0010037 Ocala, Florida, United States
View all 121 locations
View Trial Details
Completed

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

NCT04638829

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Sobi Site 110 Tucson, Arizona, United States
  • Sobi Site 119 Whittier, California, United States
  • Sobi Site 123 Washington D.C., District of Columbia, United States
  • Sobi Site 129 Miami, Florida, United States
View all 20 locations
View Trial Details
Completed

A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP

NCT03524612

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • Hematology Oncology Association of Rockland Nyack, New York, United States
  • Case Western Reserve Cleveland, Ohio, United States
  • Novartis Investigative Site Linz, Austria
  • Novartis Investigative Site Salvador, Estado de Bahia, Brazil
View all 32 locations
View Trial Details
Completed

Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation

NCT00621894

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of California San Diego Medical Center San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Davis, Posteraro and Wasser, MD's LLP Manchester, Connecticut, United States
  • Baptist Cancer Institute Jacksonville, Florida, United States
View all 15 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

NCT04687072

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigator Site 0010116 Springdale, Arkansas, United States
  • Investigator site 0010036 Los Angeles, California, United States
  • Investigator Site 0010045 Washington D.C., District of Columbia, United States
  • Investigator Site 0010104 Weston, Florida, United States
View all 200 locations
View Trial Details
Completed

Immunomodulation With Eltrombopag in ITP

NCT04812483

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Aarau Cantonal Hospital, Division of Hematology Aarau, Switzerland
  • University Children's Hospital Basel (UKBB) Basel, Switzerland
  • University Hospital Basel, Division of Hematology Basel, Switzerland
  • University Hospital Bern, Division of Hematology Bern, Switzerland
View Trial Details
Completed

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults

NCT05422365

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Municipal non-profit enterprise "City Clinical Hospital No. 4" of the Dnipro City Council Dnipro, Ukraine
  • Municipal non-profit enterprise "Khmelnytskyi Regional Hospital" of the Khmelnytskyi Regional Council Khmelnytskyi, Ukraine
  • Municipal Non-Profit Enterprise "Kirovohrad Regional Hospital of the Kirovohrad Regional Council" Kropyvnytskyi, Ukraine
  • Medical Center "OK!Clinic+" of the Company with Limited Liability "International Institute of Clinical Research" Kyiv, Ukraine
View Trial Details
Completed

Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies

NCT02222545

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
Locations
  • Omeros Investigational Site Duarte, California, United States
  • Omeros Investigational Site Rochester, Minnesota, United States
  • Omeros Investigational Site New York, United States
  • Omeros Investigational Site Durham, North Carolina, United States
View all 24 locations
View Trial Details

Related conditions